Advertisement
Celcuity Inc.

Celcuity Inc. (CELC) Stock Overview

Explore Celcuity Inc.’s financial performance, market position, analyst ratings, and future outlook.

CELCNASDAQ
HealthcareBiotechnology
$92.47
$3.52(3.96%)
U.S. Market opens in 16h 7m
Advertisement

Celcuity Inc. (CELC)

Meyka AI Score

Z

Key Financials

Market Cap4.5B
P/E Ratio-24.93
EPS (TTM)$-3.90
ROE-2.45%
Fundamental Analysis

AI Price Forecasts

1 Month$108.23
3 Months$73.00
1 Year Target$55.78

CELC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Celcuity Inc. (CELC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 27.17, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $55.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -24.93 and a market capitalization of 4.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.96%
5-Day Change
-29.46%
1-Month Change
-36.22%
3-Month Change
-17.57%
6-Month Change
-12.66%
Year-to-Date (YTD) Change
-7.29%
1-Year Change
671.87%
3-Year Change
756.20%
5-Year Change
243.88%
All-Time (Max) Change
547.10%

Contact Information

763 392 0767
16305–36th Avenue North, Minneapolis, MN, 55446

Company Facts

87 Employees
IPO DateSep 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions